Copyright
©The Author(s) 2020.
World J Biol Chem. Sep 27, 2020; 11(2): 14-29
Published online Sep 27, 2020. doi: 10.4331/wjbc.v11.i2.14
Published online Sep 27, 2020. doi: 10.4331/wjbc.v11.i2.14
Figure 3 Treatment modalities related to the immunological mechanisms observed during coronavirus disease 2019.
ACE2: Angiotensin-converting enzyme 2; ARDS: Acute respiratory distress syndrome; MHC: Major histocompatibility complex; MSCs: Mesenchymal stromal/stem cells; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.
- Citation: Velikova TV, Kotsev SV, Georgiev DS, Batselova HM. Immunological aspects of COVID-19: What do we know? World J Biol Chem 2020; 11(2): 14-29
- URL: https://www.wjgnet.com/1949-8454/full/v11/i2/14.htm
- DOI: https://dx.doi.org/10.4331/wjbc.v11.i2.14